On October 15, Astera Labs, Inc. fell 3.15% in After-Hours Trading, trading at $291.0 per share, with turnover of $68.98 million.
The clearest catalyst remained the earlier rating downgrade by Northland Securities to market perform from outperform, while selling pressure continued ahead of the company’s November 3 third-quarter earnings release.
Recent market updates showed this downgrade had already weighed on the stock across multiple sessions, including pre-market and regular trading declines on October 13 and October 14. While consensus expectations were not described as materially weakening, the stock remained under pressure from profit-taking before earnings. Analysts on average still rate the shares overweight or buy-equivalent, with a mean target price of $416.78, and the market currently expects next-quarter EPS of $0.83. The latest after-hours weakness appears consistent with that continuing event-driven overhang.
(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)
Comments